Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov 23:8:723387.
doi: 10.3389/fvets.2021.723387. eCollection 2021.

Assessing Intestinal Health. In Vitro and Ex vivo Gut Barrier Models of Farm Animals: Benefits and Limitations

Affiliations
Review

Assessing Intestinal Health. In Vitro and Ex vivo Gut Barrier Models of Farm Animals: Benefits and Limitations

Federico Ghiselli et al. Front Vet Sci. .

Abstract

Animal performance is determined by the functionality and health of the gastrointestinal tract (GIT). Complex mechanisms and interactions are involved in the regulation of GIT functionality and health. The understanding of these relationships could be crucial for developing strategies to improve animal production yields. The concept of "gut health" is not well defined, but this concept has begun to play a very important role in the field of animal science. However, a clear definition of GIT health and the means by which to measure it are lacking. In vitro and ex vivo models can facilitate these studies, creating well-controlled and repeatable conditions to understand how to improve animal gut health. Over the years, several models have been developed and used to study the beneficial or pathogenic relationships between the GIT and the external environment. This review aims to describe the most commonly used animals' in vitro or ex vivo models and techniques that are useful for better understanding the intestinal health of production animals, elucidating their benefits and limitations.

Keywords: ex vivo model; farm animal; gut barrier; in vitro model; intestinal health.

PubMed Disclaimer

Conflict of interest statement

BR was employed by company Vetagro S.p.A. AP and EG serves in the board of Directors of Vetagro S.p.A. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The figure represents the different cell sources for in vitro studies. Epithelial cells can derive directly from intestinal tissue or from tumors. The intestine allows the isolations of primary cells or stem cells to produce enteroids and organoids. On the other hand, intestinal tumors generate continuous cell cultures. These can also be obtained by immortalization techniques of primary cells. Cells can be seeded on specific inserts, alone or in co-culture with other cell types to create either monolayers or a more representative intestinal barrier model, respectively. Created with BioRender.com.
Figure 2
Figure 2
The figure represents the different ex vivo models. The Using chamber or the inTESTine™ system works by removing a segment of intestinal mucosa from an animal, which is then mounted between two halves of a chamber filled with physiological buffer to simulate the mucosal and basolateral passage flow. In everted intestinal rings, the animal's intestine is cut into ring slices and transferred into oxygenated culture media. This model is a useful tool for investigating uptake into intestinal cells and metabolism in different regions of the intestine—Created with BioRender.com.

References

    1. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. (2009) 9:799–809. 10.1038/nri2653 - DOI - PubMed
    1. Kogut MH, Arsenault RJ. Editorial: gut health: the new paradigm in food animal production. Front Vet Sci. (2016) 3:71. 10.3389/fvets.2016.00071 - DOI - PMC - PubMed
    1. Pastorelli L, De Salvo C, Mercado JR, Vecchi M, Pizarro TT. Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics. Front Immunol. (2013) 4:28. 10.3389/fimmu.2013.00280 - DOI - PMC - PubMed
    1. Clarke G, Stilling RM, Kennedy PJ, Stanton C, Cryan JF, Dinan TG. Minireview: gut microbiota: the neglected endocrine organ. Mol Endocrinol Baltim Md. (2014) 28:1221–38. 10.1210/me.2014-1108 - DOI - PMC - PubMed
    1. Smirnova MG, Guo L, Birchall JP, Pearson JP, LPS . up-Regulates mucin and cytokine mrna expression and stimulates mucin and cytokine secretion in goblet cells. Cell Immunol. (2003) 221:42–9. 10.1016/S0008-8749(03)00059-5 - DOI - PubMed

LinkOut - more resources